Intelligent medicine storage system and method thereof

Abstract

The invention discloses an intelligent medicine storage system and method, and particularly relates to the technical field of medicine storage, and the method comprises the steps: obtaining the environment information of a medicine in a storage process, and obtaining an environment disqualification coefficient according to the environment information; obtaining inventory data of the medicines in the storage process, and obtaining an inventory coefficient according to the inventory data; packaging information of the medicine in the storage process is obtained, and a packaging breakage coefficient is obtained according to the packaging information; according to the environment disqualification coefficient, the inventory coefficient and the package damage coefficient, obtaining the state coefficient of the medicine in the storage process; according to the state coefficient of the medicine in the storage process, the inspection period and the inspection medicine amount of the medicine in the storage process are adjusted; therefore, in the actual medicine storage process, the inspection period and the inspection medicine amount can be adjusted according to the influence of different storage conditions on the medicine quality, the change of the medicine quality can be found in time, and the risk that the quality of the medicine is reduced in the storage period is reduced.

Description

Technical Field

[0001] The present invention relates to the technical field of drug storage, and in particular to an intelligent drug storage system and method thereof. Background Art

[0002] Psychotropic drugs refer to drugs used to treat or regulate mental illnesses and psychological disorders. They are often used to relieve anxiety, depression, schizophrenia, bipolar disorder and other symptoms. Psychotropic drugs are usually very sensitive to environmental conditions when they are stored, especially factors such as temperature, humidity, light and air exposure, which may affect the stability and effectiveness of the drugs. For example, high temperature may accelerate the degradation of drugs, resulting in a decrease in efficacy; excessive humidity may cause drugs to absorb moisture and deteriorate; excessive light may cause certain psychotropic drugs to undergo photochemical reactions, affecting their efficacy. In addition, the integrity of drug packaging is also key. Damaged packaging or poor sealing may cause the drug to come into contact with air, further accelerating its quality changes. Therefore, when storing psychotropic drugs, environmental conditions must be strictly controlled, and the detection cycle and monitoring frequency must be adjusted according to the specific storage status to ensure the effectiveness and safety of the drugs.

[0003] When storing psychotropic drugs, in general, in order to ensure the storage quality of the drugs, the stored drugs are checked regularly and quantitatively to ensure that the drugs are always kept in the best use condition; however, in the actual drug storage process, different storage conditions have different effects on drug quality. If the drug quality inspection is still carried out according to the previously set inspection cycle and inspection dosage, changes in drug quality may not be discovered in time, resulting in the risk of drug quality degradation during storage. Summary of the invention

[0004] The purpose of the present invention is to solve the problem and to propose an intelligent medicine storage system and method.

[0005] In a first aspect of the present invention, a smart drug storage method is first proposed, the method comprising the following steps:

[0006] Obtain environmental information of drugs during storage and obtain environmental unqualified coefficients based on the environmental information;

[0007] Obtain the inventory data of the drugs during storage, and obtain the inventory coefficient based on the inventory data;

[0008] Obtain the packaging information of the drug during storage, and obtain the packaging damage coefficient based on the packaging information;

[0009] The state coefficient of the drug during storage is obtained according to the environmental unqualified coefficient, inventory coefficient and package damage coefficient;

[0010] The inspection cycle and the amount of drugs to be inspected during the storage process are adjusted according to the status coefficient of the drugs during the storage process.

[0011] Optionally, obtaining the environmental unqualified coefficient according to the environmental information includes:

[0012] Get the actual value of each type of environment affecting the drug at different times during the storage process and mark it as G 实 b , f represents the number of actual values ​​of each type of environmental impact, b = 1, 2, 3, 4, ..., n, n is a positive integer;

[0013] The actual value G of each type of environment that affects 实 b The actual value of the impact environment type outside the corresponding preset storage environment range (RF, RG) is re-marked as R h , h represents the actual value G of each type of environmental impact 实 b The number of times the device is outside the corresponding preset storage environment range (RF, RG), h = 1, 2, 3, 4, ..., k, where k is a positive integer;

[0014] Calculate the environmental non-conformity coefficient Wsd, the calculation formula is:

[0015]

[0016] Where i is the order number of the influencing environment type, t is the total number of influencing environment types, and t is a positive integer.

[0017] Optionally, obtaining the inventory coefficient according to the inventory data includes:

[0018] Get the actual inventory of the drug at different times during the storage process and mark it as E a , a represents the number of the actual inventory of drugs at different times, a=1, 2, 3, 4, ..., v, v is a positive integer;

[0019] According to the actual inventory of drugs at different times E a and the preset maximum actual drug inventory W at the corresponding time a The drug consumption coefficient DF is obtained, and the calculation formula is:

[0020] Obtain the time from the production date to the current date of the drug as the production time, and obtain the production time of all drugs during the storage process to obtain the average production time Yu;

[0021] Calculate the inventory coefficient using the formula: Mgh = a1×DF+a2×Yu; where Mgh is the inventory coefficient, and a1 and a2 represent the preset weight coefficients of the drug consumption coefficient and the average production time.

[0022] Optionally, obtaining the package damage coefficient according to the package information includes:

[0023] Obtain the total types of drug packaging damage during the storage process, and obtain the duration of each packaging damage type and the corresponding packaging damage score to obtain the packaging damage coefficient. The calculation formula is:

[0024]

[0025] Where Bzx is the package damage coefficient, FR e is the duration of the e-th package damage type, WR e is the score of the e-th package damage type, and m is the total number of package damage types.

[0026] Optionally, the state coefficient of the drug during storage is obtained according to the environmental unqualified coefficient, the inventory coefficient and the package damage coefficient, including:

[0027] The environmental unqualified coefficient, inventory coefficient and packaging damage coefficient are normalized, and the state coefficient is obtained according to the normalized environmental unqualified coefficient, inventory coefficient and packaging damage coefficient. The calculation formula is:

[0028]

[0029] Where QWE is the state coefficient, Bza, RF and DR are the normalized environmental unqualified coefficient, inventory coefficient and packaging damage coefficient, respectively, b1, b2 and b3 are the preset proportional coefficients of the normalized environmental unqualified coefficient, inventory coefficient and packaging damage coefficient, respectively, and b1, b2 and b3 are all greater than 0.

[0030] Optionally, adjusting the inspection period and the inspection amount of the drugs during the storage process according to the state coefficient of the drugs during the storage process includes:

[0031] The state coefficient is compared with a preset state coefficient threshold, and when the state coefficient is not less than the preset state coefficient threshold, it is determined that the inspection cycle and the inspection amount of the drug during the storage process need to be adjusted;

[0032] When the state coefficient is less than the preset state coefficient threshold, there is no need to adjust the inspection cycle and inspection amount of the drugs during the storage process.

[0033] Optionally, the method for adjusting the inspection cycle and the inspection drug amount includes:

[0034] The new inspection cycle is obtained according to the originally set inspection cycle and state coefficient. The calculation formula is: WET = TGH × (1-QWE), where WET is the new inspection cycle, QWE is the state coefficient, and TGH is the originally set inspection cycle;

[0035] The new inspection drug amount is obtained according to the originally set inspection drug amount and state coefficient. The calculation formula is: BRF=YHJ×(1+QWE), where BRF is the new inspection drug amount, QWE is the state coefficient, and YHJ is the originally set inspection drug amount.

[0036] In a second aspect of the present invention, an intelligent medicine storage system is provided, the system comprising:

[0037] Environmental non-conformity module: obtains environmental information of drugs during storage and obtains environmental non-conformity coefficient based on the environmental information;

[0038] Inventory module: obtain the inventory data of drugs during storage and obtain the inventory coefficient based on the inventory data;

[0039] Packaging damage module: obtains the packaging information of the drug during storage, and obtains the packaging damage coefficient based on the packaging information;

[0040] Storage status module: obtain the status coefficient of the drug during storage according to the environmental unqualified coefficient, inventory coefficient and packaging damage coefficient;

[0041] Inspection and storage module: adjust the inspection cycle and inspection amount of drugs during the storage process according to the status coefficient of the drugs during the storage process.

[0042] Beneficial effects of the present invention:

[0043] The present invention proposes an intelligent drug storage system and method thereof, which obtains environmental information of drugs during storage and obtains an environmental unqualified coefficient according to the environmental information; obtains inventory data of drugs during storage and obtains an inventory coefficient according to the inventory data; obtains packaging information of drugs during storage and obtains a packaging damage coefficient according to the packaging information; obtains a state coefficient of drugs during storage according to the environmental unqualified coefficient, the inventory coefficient and the packaging damage coefficient; and adjusts the inspection period and the amount of drugs during storage according to the state coefficient of drugs during storage; in this way, in the actual drug storage process, the inspection period and the amount of drugs can be adjusted according to the influence of different storage conditions on the quality of drugs, and the changes in the quality of drugs can be discovered in time, so that the risk of quality degradation of drugs during storage is reduced. BRIEF DESCRIPTION OF THE DRAWINGS

[0044] The present invention will be further described below in conjunction with the accompanying drawings.

[0045] Figure 1 A flow chart of an intelligent drug storage method provided by an embodiment of the present invention;

[0046] Figure 2 A framework diagram of an intelligent drug storage system provided in an embodiment of the present invention. DETAILED DESCRIPTION

[0047] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0048] Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in the field without making any creative work shall fall within the scope of protection of the present invention.

[0049] The embodiment of the present invention provides a smart drug storage method. Figure 1 , Figure 1 A flowchart of a smart drug storage method provided by an embodiment of the present invention. The method comprises the following steps:

[0050] Obtain environmental information of drugs during storage and obtain environmental unqualified coefficients based on the environmental information;

[0051] Obtain the inventory data of the drugs during storage, and obtain the inventory coefficient based on the inventory data;

[0052] Obtain the packaging information of the drug during storage, and obtain the packaging damage coefficient based on the packaging information;

[0053] The state coefficient of the drug during storage is obtained according to the environmental unqualified coefficient, inventory coefficient and package damage coefficient;

[0054] The inspection cycle and the amount of drugs to be inspected during the storage process are adjusted according to the status coefficient of the drugs during the storage process.

[0055] Based on an intelligent drug storage method provided by an embodiment of the present invention, through the above-mentioned method, in the actual drug storage process, the inspection cycle and the amount of drug inspection can be adjusted according to the impact of different storage conditions on the quality of the drugs, and changes in the quality of the drugs can be discovered in time, thereby reducing the risk of quality degradation of the drugs during storage.

[0056] In one embodiment, obtaining the environmental unqualified coefficient according to the environmental information includes:

[0057] Get the actual value of each type of environment affecting the drug at different times during the storage process and mark it as G 实 b , f represents the number of actual values ​​of each type of environmental impact, b = 1, 2, 3, 4, ..., n, n is a positive integer;

[0058] The actual value G of each type of environment that affects 实 b The actual value of the impact environment type outside the corresponding preset storage environment range (RF, RG) is re-marked as R h , h represents the actual value G of each type of environmental impact 实 b The number of times the device is outside the corresponding preset storage environment range (RF, RG), h = 1, 2, 3, 4, ..., k, where k is a positive integer;

[0059] Calculate the environmental non-conformity coefficient Wsd, the calculation formula is:

[0060]

[0061] Where i is the order number of the influencing environment type, t is the total number of influencing environment types, and t is a positive integer.

[0062] It should be noted that the influencing environment types can be factors such as temperature, humidity, light, air pressure, gas concentration (such as oxygen, carbon dioxide), vibration, noise, etc. These factors will affect the stability and effectiveness of psychotropic drugs during the storage process; in general, temperature: psychotropic drugs usually have a specific storage temperature range, and too high or too low temperature will cause psychotropic drugs to fail or deteriorate in quality; humidity: excessive humidity may cause psychotropic drugs to absorb moisture, affecting their chemical composition, especially for tablets and capsules; light: some psychotropic drugs are sensitive to light, and exposure to strong light may cause degradation or failure; air pressure: for gaseous psychotropic drugs or aerosol psychotropic drugs, changes in air pressure may affect their stability; gas concentration: changes in the concentration of gases such as oxygen and carbon dioxide, especially in a sealed environment, may cause oxidation or other chemical reactions of psychotropic drugs; vibration and noise: some psychotropic drugs are sensitive to vibration and noise, such as liquid psychotropic drugs or injections may be affected by vibration, resulting in stratification or decreased stability.

[0063] It should be noted that the preset storage environment range corresponding to each environmental impact type is set by professionals based on actual conditions and will not be limited or elaborated on in detail;

[0064] It should be noted that the environmental unqualified coefficient refers to the degree of deviation of environmental conditions during the storage of psychotropic drugs. When the degree of deviation is greater, that is, the environmental unqualified coefficient is greater, it means that the quality inspection of psychotropic drugs according to the previously set inspection cycle and inspection amount may not be able to detect changes in the quality of psychotropic drugs in time, resulting in the risk of quality degradation of psychotropic drugs during storage. The reason is that when the environmental unqualified coefficient is high, it indicates that the degree of deviation of environmental conditions from the preset standards during the storage of psychotropic drugs is large, which may have a significant impact on the stability and quality of psychotropic drugs. Abnormal fluctuations in environmental factors such as temperature, humidity, and light may cause psychotropic drugs to accelerate degradation, failure, or other adverse reactions. Since the conventionally set inspection cycle and inspection amount are usually based on stability expectations under normal environmental conditions, the fixed inspection frequency may not be sufficient to capture the quality changes caused by these environmental fluctuations in time. Therefore, when environmental conditions are not good, quality problems of psychotropic drugs may have occurred before the inspection, and conventional testing may not be able to detect these problems in time. In order to effectively deal with these risks, it is necessary to dynamically adjust the testing cycle and inspection volume, and increase the frequency and scope of testing according to changes in the environmental unqualified coefficient, so as to ensure the stable quality of psychotropic drugs during storage and prevent the quality of psychotropic drugs from deteriorating due to deviations in environmental conditions.

[0065] In one embodiment, obtaining the inventory coefficient according to the inventory data includes:

[0066] Get the actual inventory of the drug at different times during the storage process and mark it as E a , a represents the number of the actual inventory of drugs at different times, a=1, 2, 3, 4, ..., v, v is a positive integer;

[0067] According to the actual inventory of drugs at different times E a and the preset maximum actual drug inventory W at the corresponding time a The drug consumption coefficient DF is obtained, and the calculation formula is:

[0068] Obtain the time from the production date to the current date of the drug as the production time, and obtain the production time of all drugs during the storage process to obtain the average production time Yu;

[0069] Calculate the inventory coefficient using the formula: Mgh = a1×DF+a2×Yu; where Mgh is the inventory coefficient, and a1 and a2 represent the preset weight coefficients of the drug consumption coefficient and the average production time.

[0070] It should be noted that a1 and a2 are set by professionals according to actual conditions. Generally, the sum of a1 and a2 is 1. For example, a1 and a2 can be 0.5 and 0.5 respectively, or other numbers, which are not specifically limited.

[0071] It should be noted that the preset maximum actual inventory of drugs is set by professionals based on actual conditions, and no specific restrictions or elaborations are made;

[0072] It should be noted that the inventory coefficient refers to the degree to which the consumption coefficient of psychotropic drugs deviates from the preset consumption during the storage of psychotropic drugs and the time that psychotropic drugs have been produced and stored. When the degree to which the consumption coefficient of psychotropic drugs deviates from the preset consumption is greater, the longer the psychotropic drugs have been produced and stored, that is, the larger the inventory coefficient is, it means that the quality inspection of psychotropic drugs according to the previously set inspection cycle and inspection dosage may not be able to timely detect changes in the quality of psychotropic drugs, resulting in the risk of quality degradation of psychotropic drugs during storage. The reason is that when the inventory coefficient is high, it means that there are significant inventory fluctuations and long storage time of psychotropic drugs during the storage process. These two factors work together to make it possible for the quality inspection of psychotropic drugs to fail to detect quality changes in time. Specifically, the deviation of the consumption coefficient of psychotropic drugs indicates that there is a large difference between the actual consumption of psychotropic drugs and the preset consumption level, which may hide potential problems in the quality of psychotropic drugs. At the same time, the longer the storage time of psychotropic drugs, the greater the risk of quality degradation, because long-term storage may cause the active ingredients of psychotropic drugs to degrade or produce other chemical reactions. The existing inspection cycle and inspection volume are usually based on the expected performance under a stable environment. When the inventory coefficient is large, environmental fluctuations and changes in storage time make such routine inspections insufficient to capture these quality changes in a timely manner. Therefore, when the inventory coefficient is large, the inspection strategy must be adjusted, including increasing the inspection frequency and expanding the inspection scope to ensure that the quality of psychotropic drugs is effectively monitored and to prevent quality degradation caused by changes in the environment and storage time.

[0073] In one embodiment, obtaining the package damage coefficient according to the package information includes:

[0074] Obtain the total types of drug packaging damage during the storage process, and obtain the duration of each packaging damage type and the corresponding packaging damage score to obtain the packaging damage coefficient. The calculation formula is:

[0075]

[0076] Where Bzx is the package damage coefficient, FR e is the duration of the e-th package damage type, WR eis the score of the e-th package damage type, and m is the total number of package damage types.

[0077] It should be noted that the ratings for packaging damage types are set by professionals based on actual situations, and are not limited or elaborated on in detail.

[0078] It should be noted that the types of package damage can include a variety of situations, such as minor damage (such as surface scratches and small cracks), moderate damage (such as larger cracks and tears), severe damage (such as complete tearing and leakage of psychotropic drugs), corrosive damage (corrosion caused by environmental factors such as humidity), sealing failure (damage to the sealing strip leading to the entry of air or pollutants) and structural damage (such as container rupture or box deformation). These different types of damage may have different degrees of impact on the quality and safety of psychotropic drugs. Therefore, when calculating the package damage coefficient, these types of damage need to be fully recorded and evaluated in order to accurately reflect the potential impact of the packaging condition on psychotropic drugs and take appropriate management measures to ensure the quality and effectiveness of psychotropic drugs.

[0079] It should be noted that the package damage coefficient refers to the degree of damage to the packaging of psychotropic drugs during the storage of psychotropic drugs. When the degree of damage to the packaging of psychotropic drugs is greater, that is, the larger the package damage coefficient, it means that the quality inspection of psychotropic drugs according to the previously set inspection cycle and inspection amount may not be able to timely detect changes in the quality of psychotropic drugs, resulting in the risk of quality degradation of psychotropic drugs during storage. The reason is that when the package damage coefficient is larger, it indicates that the damage to the packaging of psychotropic drugs is more serious, which means that the protective effect of the packaging on psychotropic drugs is reduced, which may cause psychotropic drugs to be exposed to inappropriate environmental conditions, such as moisture, air or pollutants. This situation may cause the quality of psychotropic drugs to deteriorate rapidly, and the previously set inspection cycle and inspection amount may not be able to adapt to this change in time. Package damage may increase the risk of quality degradation of psychotropic drugs during storage, because the conventional inspection frequency and inspection amount are usually based on the assumption that the packaging is in good condition, and fail to effectively cover quality problems caused by package damage. Therefore, when the package damage coefficient is large, the detection strategy must be adjusted to increase the sensitivity to changes in the quality of psychotropic drugs, ensure timely detection and handling of quality problems, and prevent the risk of quality degradation of psychotropic drugs during storage.

[0080] In one embodiment, the state coefficient of the drug during storage is obtained according to the environmental unqualified coefficient, the inventory coefficient and the package damage coefficient, including:

[0081] The environmental unqualified coefficient, inventory coefficient and packaging damage coefficient are normalized, and the state coefficient is obtained according to the normalized environmental unqualified coefficient, inventory coefficient and packaging damage coefficient. The calculation formula is:

[0082]

[0083] Where QWE is the state coefficient, Bza, RF and DR are the normalized environmental unqualified coefficient, inventory coefficient and packaging damage coefficient, respectively, b1, b2 and b3 are the preset proportional coefficients of the normalized environmental unqualified coefficient, inventory coefficient and packaging damage coefficient, respectively, and b1, b2 and b3 are all greater than 0.

[0084] It should be noted that b1, b2, and b3 are set by professionals according to actual conditions. Generally, the sum of b1, b2, and b3 is 1. For example, b1, b2, and b3 can be 0.3, 0.3, and 0.4, respectively, or other numbers, without specific limitation.

[0085] In one embodiment, adjusting the inspection period and the inspection amount of the medicine during the storage process according to the state coefficient of the medicine during the storage process includes:

[0086] The state coefficient is compared with a preset state coefficient threshold, and when the state coefficient is not less than the preset state coefficient threshold, it is determined that the inspection cycle and the inspection amount of the drug during the storage process need to be adjusted;

[0087] When the state coefficient is less than the preset state coefficient threshold, there is no need to adjust the inspection cycle and inspection amount of the drugs during the storage process.

[0088] It should be noted that the preset state coefficient threshold is set by professionals according to actual conditions and will not be limited or elaborated on in detail.

[0089] In one embodiment, the method for adjusting the inspection period and the inspection drug amount includes:

[0090] The new inspection cycle is obtained according to the originally set inspection cycle and state coefficient. The calculation formula is: WET = TGH × (1-QWE), where WET is the new inspection cycle, QWE is the state coefficient, and TGH is the originally set inspection cycle;

[0091] The new inspection drug amount is obtained according to the originally set inspection drug amount and state coefficient. The calculation formula is: BRF=YHJ×(1+QWE), where BRF is the new inspection drug amount, QWE is the state coefficient, and YHJ is the originally set inspection drug amount.

[0092] In one implementation, by adjusting the inspection cycle and the amount of psychotropic drugs inspected in the above manner, the quality inspection strategy can be dynamically optimized according to the actual packaging damage coefficient and state coefficient. This adjustment ensures that when the packaging is severely damaged, the inspection frequency and the amount of psychotropic drugs are increased, thereby increasing the sensitivity to changes in the quality of psychotropic drugs. This not only enables the discovery of potential problems in the quality of psychotropic drugs more timely and reduces the risk of quality degradation due to packaging defects, but also effectively prevents quality risks that are missed due to insufficient testing. This flexible adjustment method improves the monitoring capability and response speed during the storage of psychotropic drugs, helps to ensure the safety and effectiveness of psychotropic drugs throughout the storage period, and ultimately ensures that psychotropic drugs can be put into use in the best condition.

[0093] Based on the same inventive concept, the present invention also provides an intelligent medicine storage system. Figure 2 , Figure 2 A framework diagram of an intelligent drug storage system provided by an embodiment of the present invention includes:

[0094] Environmental non-conformity module: obtains environmental information of drugs during storage and obtains environmental non-conformity coefficient based on the environmental information;

[0095] Inventory module: obtain the inventory data of drugs during storage and obtain the inventory coefficient based on the inventory data;

[0096] Packaging damage module: obtains the packaging information of the drug during storage, and obtains the packaging damage coefficient based on the packaging information;

[0097] Storage status module: obtain the status coefficient of the drug during storage according to the environmental unqualified coefficient, inventory coefficient and packaging damage coefficient;

[0098] Inspection and storage module: adjust the inspection cycle and inspection amount of drugs during the storage process according to the status coefficient of the drugs during the storage process.

[0099] Based on an intelligent drug storage system provided by an embodiment of the present invention, through the above-mentioned method, in the actual drug storage process, the inspection cycle and the amount of drug inspection can be adjusted according to the impact of different storage conditions on the quality of the drugs, and changes in the quality of the drugs can be discovered in time, thereby reducing the risk of quality degradation of the drugs during storage.

[0100] The above is a detailed description of an embodiment of the present invention, but the content is only a preferred embodiment of the present invention and cannot be considered to limit the scope of implementation of the present invention. All equivalent changes and improvements made within the scope of the present invention should still fall within the scope of the patent coverage of the present invention.

Claims

1. A smart drug storage method, characterized in that: The following steps are involved: Obtain environmental information of drugs during storage and obtain environmental unqualified coefficients based on the environmental information; Obtain the inventory data of the drugs during storage, and obtain the inventory coefficient based on the inventory data; Obtain the packaging information of the drug during storage, and obtain the packaging damage coefficient based on the packaging information; The state coefficient of the drug during storage is obtained according to the environmental unqualified coefficient, inventory coefficient and package damage coefficient; The inspection cycle and the amount of drugs to be inspected during the storage process are adjusted according to the status coefficient of the drugs during the storage process.

2. The intelligent drug storage method according to claim 1, characterized in that: The environmental non-conformity coefficients obtained based on environmental information include: Get the actual value of each type of environment affecting the drug at different times during the storage process and mark it as G 实 b , f represents the number of actual values ​​of each type of environmental impact, b = 1, 2, 3, 4, ..., n, n is a positive integer; The actual value G of each type of environment that affects 实 b The actual value of the impact environment type outside the corresponding preset storage environment range (RF, RG) is re-marked as R h , h represents the actual value G of each type of environmental impact 实 b The number of times the device is outside the corresponding preset storage environment range (RF, RG), h = 1, 2, 3, 4, ..., k, where k is a positive integer; Calculate the environmental non-conformity coefficient Wsd, the calculation formula is: Where i is the order number of the influencing environment type, t is the total number of influencing environment types, and t is a positive integer.

3. The intelligent drug storage method according to claim 2, characterized in that: The inventory coefficients obtained based on inventory data include: Get the actual inventory of the drug at different times during the storage process and mark it as E a , a represents the number of the actual inventory of drugs at different times, a=1, 2, 3, 4, ..., v, v is a positive integer; According to the actual inventory of drugs at different times E a and the preset maximum actual drug inventory W at the corresponding time a The drug consumption coefficient DF is obtained, and the calculation formula is: Obtain the time from the production date to the current date of the drug as the production time, and obtain the production time of all drugs during the storage process to obtain the average production time Yu; Calculate the inventory coefficient using the formula: Mgh = a1×DF+a2×Yu; where Mgh is the inventory coefficient, and a1 and a2 represent the preset weight coefficients of the drug consumption coefficient and the average production time.

4. The intelligent drug storage method according to claim 3, characterized in that: The packaging damage coefficient obtained based on the packaging information includes: Obtain the total types of drug packaging damage during the storage process, and obtain the duration of each packaging damage type and the corresponding packaging damage score to obtain the packaging damage coefficient. The calculation formula is: Where Bzx is the package damage coefficient, FR e is the duration of the e-th package damage type, WR e is the score of the e-th package damage type, and m is the total number of package damage types.

5. The intelligent drug storage method according to claim 4, characterized in that: The status coefficients of the drugs during storage are obtained based on the environmental unqualified coefficient, inventory coefficient and packaging damage coefficient, including: The environmental unqualified coefficient, inventory coefficient and packaging damage coefficient are normalized, and the state coefficient is obtained according to the normalized environmental unqualified coefficient, inventory coefficient and packaging damage coefficient. The calculation formula is: Where QWE is the state coefficient, Bza, RF and DR are the normalized environmental unqualified coefficient, inventory coefficient and packaging damage coefficient, respectively, b1, b2 and b3 are the preset proportional coefficients of the normalized environmental unqualified coefficient, inventory coefficient and packaging damage coefficient, respectively, and b1, b2 and b3 are all greater than 0.

6. The intelligent drug storage method according to claim 1, characterized in that: Adjusting the inspection cycle and the amount of drugs to be inspected during the storage process according to the status coefficient of the drugs during the storage process includes: The state coefficient is compared with a preset state coefficient threshold, and when the state coefficient is not less than the preset state coefficient threshold, it is determined that the inspection cycle and the inspection amount of the drug during the storage process need to be adjusted; When the state coefficient is less than the preset state coefficient threshold, there is no need to adjust the inspection cycle and inspection amount of the drugs during the storage process.

7. The intelligent drug storage method according to claim 6, characterized in that: The method for adjusting the inspection cycle and the inspection drug amount includes: The new inspection cycle is obtained according to the originally set inspection cycle and state coefficient. The calculation formula is: WER = TGH × (1-QWE), where WER is the new inspection cycle, QWE is the state coefficient, and TGH is the originally set inspection cycle; The new inspection drug amount is obtained according to the originally set inspection drug amount and state coefficient. The calculation formula is: BRF=YHJ×(1+QWE), where BRF is the new inspection drug amount, QWE is the state coefficient, and YHJ is the originally set inspection drug amount.

8. An intelligent drug storage system, characterized in that: The system comprises: Environmental non-conformity module: obtains environmental information of drugs during storage and obtains environmental non-conformity coefficient based on the environmental information; Inventory module: obtain the inventory data of drugs during storage and obtain the inventory coefficient based on the inventory data; Packaging damage module: obtains the packaging information of the drug during storage, and obtains the packaging damage coefficient based on the packaging information; Storage status module: obtain the status coefficient of the drug during storage according to the environmental unqualified coefficient, inventory coefficient and packaging damage coefficient; Inspection and storage module: adjust the inspection cycle and inspection amount of drugs during the storage process according to the status coefficient of the drugs during the storage process.

Images